The clinical course of IgA-nephropathy and Henoch-Schönlein purpura following renal transplantation.
Recurrence of IgA-nephropathy and Henoch-Schönlein purpura is a common finding after renal transplantation. From 1970 to 1984, 1788 transplants were performed at our center. 13 patients had IgA-nephropathy and 3 patients had Henoch-Schönlein purpura. No patient with Henoch-Schönlein purpura had a proved recurrence. Six patients with IgA-nephropathy had a recurrence of IgA disease in the allograft within 3 to 8 months of transplantation. Three patients with a recurrence have retained their kidneys with stable renal function (follow-up of 1.7-2.7 years). Two of these patients lost their graft from severe rejection. One patient, who received an HLA-identical transplant, lost the graft from recurrent IgA disease associated with crescenteric glomerulonephritis. We found no difference in the prevalence of HLA-B 35 among the IgA patients compared with our total transplant population. IgA patients who received living related transplants had a higher recurrence rate of IgA in their allograft when compared with recipients of cadaveric kidneys (83% vs. 14%). Some caution is recommended in using related donors, especially HLA-identical siblings in patients with renal failure secondary to IgA-nephropathy.
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D005922:Glomerulonephritis, IGA / Q000150:complications*; D006084:Graft Rejection; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D011695:IgA Vasculitis / Q000150:complications*; D016030:Kidney Transplantation; D008297:Male; D012008:Recurrence
D006680:HLA Antigens